Literature DB >> 25908090

Status epilepticus in adults.

John P Betjemann1, Daniel H Lowenstein2.   

Abstract

Status epilepticus is a common neurological emergency with considerable associated health-care costs, morbidity, and mortality. The definition of status epilepticus as a prolonged seizure or a series of seizures with incomplete return to baseline is under reconsideration in an effort to establish a more practical definition to guide management. Clinical research has focused on early seizure termination in the prehospital setting. The approach of early escalation to anaesthetic agents for refractory generalised convulsive status epilepticus, rather than additional trials of second-line anti-epileptic drugs, to avoid neuronal injury and pharmaco-resistance associated with prolonged seizures is gaining momentum. Status epilepticus is also increasingly identified in the inpatient setting as the use of extended electroencephalography monitoring becomes more commonplace. Substantial further research to enable early identification of status epilepticus and efficacy of anti-epileptic drugs will be important to improve outcomes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25908090     DOI: 10.1016/S1474-4422(15)00042-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  79 in total

1.  Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients.

Authors:  Chloe E Hill; Leah J Blank; Dylan Thibault; Kathryn A Davis; Nabila Dahodwala; Brian Litt; Allison W Willis
Journal:  Neurology       Date:  2018-11-30       Impact factor: 9.910

2.  Treatment of Convulsive Status Epilepticus.

Authors:  Eric H Grover; Yara Nazzal; Lawrence J Hirsch
Journal:  Curr Treat Options Neurol       Date:  2016-03       Impact factor: 3.598

3.  The SAMUKeppra study in prehospital status epilepticus: lessons for future study.

Authors:  Andrew C Schomer; Jaideep Kapur
Journal:  Ann Transl Med       Date:  2016-12

Review 4.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

5.  [Neurological intensive care medicine : Intensive medical care studies from 2018-2019].

Authors:  D Michalski; C Jungk; T Brenner; M Dietrich; C Nusshag; M A Weigand; C J Reuß; C Beynon; M Bernhard
Journal:  Anaesthesist       Date:  2020-02       Impact factor: 1.041

6.  Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y1 Receptor in Experimental Epilepsy.

Authors:  Mariana Alves; Laura De Diego Garcia; Giorgia Conte; Eva M Jimenez-Mateos; Beatrice D'Orsi; Amaya Sanz-Rodriguez; Jochen H M Prehn; David C Henshall; Tobias Engel
Journal:  J Neurosci       Date:  2019-05-02       Impact factor: 6.167

7.  HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window.

Authors:  Junli Zhao; Yang Zheng; Keyue Liu; Junzi Chen; Nanxi Lai; Fan Fei; Jiaying Shi; Cenglin Xu; Shuang Wang; Masahiro Nishibori; Yi Wang; Zhong Chen
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

8.  Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus.

Authors:  Suchitra Joshi; Karthik Rajasekaran; Huayu Sun; John Williamson; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2017-04-02       Impact factor: 5.996

Review 9.  Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities.

Authors:  Dinesh Upadhya; Olagide W Castro; Raghavendra Upadhya; Ashok K Shetty
Journal:  Mol Neurobiol       Date:  2018-01-25       Impact factor: 5.590

Review 10.  Newer Antiepileptic Drugs for Status Epilepticus in Adults: What's the Evidence?

Authors:  Isabelle Beuchat; Jan Novy; Andrea O Rossetti
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.